A股異動丨錦富技術(300128.SZ)跌4.34% 重大資產重組或將吿吹
格隆匯8月12日丨錦富技術(300128.SZ)跌4.34%,盤中一度大跌約10%,現報4.41元,總市值48億元。錦富技術昨日發佈《關於收到交易對方擬單方面終止重大資產重組相關協議通知的風險提示性公吿》,稱交易對方擬單方面終止重大資產重組相關協議。此前公司擬通過發行股份及支付現金的方式購買寧欣、永新縣嘉辰商務信息諮詢中心(有限合夥)合計持有的蘇州工業園區久泰精密電子有限公司70%股權,同時向不超過35名特定投資者發行股份募集配套資金。公司原本打算通過收購來開拓市場,一旦收購失敗後,未來公司也會面臨不確定性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.